Promotie onderzoek

Kwaliteitsverbeteronderzoek naar veilige toediening van parenteralia op verpleegafdelingen. Dit betreft o.a. onderzoek naar het verbeteren van de effectiviteit van de dubbelcheck. Zo wordt gekeken hoe het risico-gestuurd uitvoeren van de dubbelcheck geïmplementeerd kan worden en wat de effecten zijn van risico-gestuurde uitvoering van de dubbelcheck.   
 

Financiering UU/docentschap.
 

The aim of this project is to explore the 3D printing of peadiatric medicines. 3D printing technology enables the creation of medications with a wide range of dosages, shapes, flavors, and drug combinations, all customized to meet the unique needs of individual patients and specific disease conditions. Once the optimal formulations have been developed, the 3D printed medicines will undergo clinical trials for testing. 

We will study compounding medication by 3D printing technology. In this way personalized medication will become more accessable. 
First formulation studies will be executed in order to provide a stable production process. After which, the use of 3D printing will be introduced in the clinical setting. Finally, the printed medication will be tested by a clinical trial.
 

We aim to develop methods to radiolabel orally inhaled drug products, allowing us to more accurately determine lung deposition through imaging techniques.